Aestus Therapeutics and Eisai have entered into a collaboration to research and develop therapeutics for the treatment of psychiatric disorders. The multi-year collaboration will involve preclinical validation of potential therapeutics leading to clinical proof-of-concept studies. Aestus has identified products with the potential to treat certain psychiatric disorders through its analysis of gene expression data sets, coupled with biological pathway mining on data from relevant disease models...